ArticleBritish journal of cancer2016

Cadherin-5: a biomarker for metastatic breast cancer with optimum efficacy in oestrogen receptor-positive breast cancers with vascular invasion.

Simon A Fry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.